CNS Pharmaceuticals Stock Price

0.0086 (3.05%)
Volume 531,940
Bid Price 0.2844
Ask Price 0.295
News -
Day High 0.31


52 Week Range


Day Low 0.2711
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CNS Pharmaceuticals Inc CNSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0086 3.05% 0.291 18:31:52
Open Price Low Price High Price Close Price Prev Close
0.285 0.2711 0.31 0.2978 0.2824
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
385 531,940 $ 0.2907557 $ 154,665 - 0.2453 - 2.68
Last Trade Time Type Quantity Stock Price Currency
18:31:52 72 $ 0.2844 USD


Draw Mode:

CNS Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.65M 40.03M 31.18M $ - $ - -0.54 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.41M 2.80%

more financials information »

CNS Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNSP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2650.310.25050.2843025462,8040.0269.81%
1 Month0.330.3980.25050.3028661411,856-0.039-11.82%
3 Months0.330.44750.24530.34247111,222,776-0.039-11.82%
6 Months1.121.380.24530.52028741,112,725-0.829-74.02%
1 Year1.852.680.24530.8439825724,824-1.56-84.27%
3 Years4.115.68990.24531.90618,896-3.82-92.92%
5 Years4.115.68990.24531.90618,896-3.82-92.92%

CNS Pharmaceuticals Description

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

Your Recent History
CNS Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.